PUBLISHER: Grand View Research | PRODUCT CODE: 1611072
PUBLISHER: Grand View Research | PRODUCT CODE: 1611072
The global maggot debridement market size is estimated to reach USD 25.7 million by 2030, registering to grow at a CAGR of 10.3% from 2025 to 2030 according to a new report by Grand View Research, Inc. The rising investment in research and development, growing prevalence of chronic diseases, and the increasing number of burn cases are the key driving factors for the market.
In the recent past, there has been a rise in the number of surgical procedures across the globe. Rising prevalence of chronic diseases, such as cancer, diabetes, and autoimmune diseases, is one of the key factors leading to an increase in the number of surgeries being performed in the country. The incidence of infectious and non-communicable diseases has increased over the past few decades.
This can be attributed to factors such as urbanization, borderline poverty in most developing states, antimicrobial resistance, and rising prevalence of food-borne diseases. An unhealthy lifestyle, lack of physical activity, alcohol abuse, and smoking are some of the major factors contributing to the rising prevalence of the abovementioned diseases. According to CDC estimates, in 2017, more than 100.0 million people were living with diabetes in the U.S.
Type II diabetes is the most common type of diabetes and 90.0% of the affected population is suffering from type II diabetes. Diabetic foot ulcer, a common complication of diabetes, typically requires wound debridement and surgical intervention to prevent foot amputation. Thus, a rising number of chronic wounds are anticipated to increase the demand for maggot debridement.